GENOMEBYTE LTD
Company number 15447699 · Active · London WC2H 9JQ
GENOMEBYTE LTD is an active private limited company (company number 15447699) incorporated on 27 January 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 January 2026, showing net assets of £0, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 100% on the prior period (£10).
By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 27 January 2024
- Next accounts due
- 31 October 2027 — in 374 days
- Confirmation statement due
- 10 February 2027 — in 111 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 January 2026
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2026 | £0 | — | — | £0 | — | — | 1 |
| 31 January 2025 | £10 | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 31/100 (grade E)
- -15 Negative net assets — Net assets £0 at 2026-01-31
- -8 Net assets falling — -100.0% vs prior period
- +4 Past first filings — Incorporated 2024-01-27
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr. Shaunik Jaden Mazumdar — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 27 January 2024
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- NEURAL PHOTONICS LIMITED — London, inc. Jan 2024
- HELENE THERAPEUTICS LIMITED — London, inc. Feb 2024
- AISTHESIS MEDICAL LIMITED — London, inc. Feb 2024
- RQBIO COVID LIMITED — London, inc. Jan 2024
- ELECTRADX UK LTD — London, inc. Feb 2024
- KODIFORM THERAPEUTICS LIMITED — London, inc. Jan 2024
All companies incorporated on 27 January 2024 · in Jan 2024.
Reminders for GENOMEBYTE LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.